🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)

Found 20 matching trials

A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

PHASE3

Participants with recurrent or metastatic (R/M) squamous cell cancer of the...

Status

Completed

Location

Multiple Locations

Start Date

2015-03-19

Trial ID

NCT02358031

Treatments Being Tested

Pembrolizumab Cisplatin Carboplatin 5-FU Cetuximab

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

PHASE1

The purpose of this study is to learn about the safety and effects of the s...

Status

Terminated

Location

Highlands Oncology Group

Start Date

2024-12-10

Trial ID

NCT06704724

Treatments Being Tested

PF-07985045 Gemcitabine Nab-paclitaxel Cetuximab Fluorouracil Oxaliplatin Leucovorin Bevacizumab Pembrolizumab Sasanlimab pemetrexed Cisplatin Paclitaxel Carboplatin PF-07284892

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

PHASE3

This is a randomized, open-label, multi-center, 3-arm, global Phase III stu...

Status

Completed

Location

Research Site

Start Date

2015-10-15

Trial ID

NCT02551159

Treatments Being Tested

MEDI4736 Tremelimumab MEDI4736+Tremelimumab Cetuximab 5-fluorouracil (5FU)Cisplatin Carboplatin

Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer

PHASE3

This trial aimed to assess efficacy and safety of cetuximab when given in c...

Status

Completed

Location

Research site

Start Date

2015-07-31

Trial ID

NCT02383966

Treatments Being Tested

Cetuximab Cisplatin/Carboplatin 5-fluorouracil

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

PHASE3

The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy ...

Status

Recruiting

Location

City of Hope

Start Date

2024-12-24

Trial ID

NCT06699212

Treatments Being Tested

ASP-1929 Photoimmunotherapy Pembrolizumab Carboplatin Cisplatin 5-fluorouracil Paclitaxel Docetaxel

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

PHASE3

Due to the increase of tumor control rate and survival rate in era of IMRT,...

Status

Unknown

Location

Multiple Locations

Start Date

2018-06-12

Trial ID

NCT03529279

Treatments Being Tested

CNG Chemotherapy NCCN Chemotherapy CNG Radiation NCCN Radiation

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

PHASE1

The purpose of this study is to learn about the safety and effects of the s...

Status

Active Not Recruiting

Location

Highlands Oncology Group, PA

Start Date

2024-06-27

Trial ID

NCT06447662

Treatments Being Tested

PF-07934040 Gemcitabine Nab-paclitaxel Cetuximab Fluorouracil Oxaliplatin Leucovorin Bevacizumab Pembrolizumab pemetrexed Cisplatin Paclitaxel Carboplatin Sasanlimab

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

PHASE3

The purpose of this trial is to investigate the efficacy of cetuximab in co...

Status

Completed

Location

Research Site

Start Date

2004-12

Trial ID

NCT00122460

Treatments Being Tested

Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)Platinum (Cisplatin or Carboplatin) + 5-FU

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

PHASE3

The purpose of this study is to evaluate the safety and efficacy of the com...

Status

Withdrawn

Location

Multiple Locations

Start Date

2017-12-15

Trial ID

NCT03342352

Treatments Being Tested

Nivolumab Epacadostat Placebo Carboplatin Cisplatin Cetuximab 5-Fluorouracil

Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

PHASE2

The primary objective of this trial is to assess the antitumor activity of ...

Status

Completed

Location

Research Site

Start Date

2009-07

Trial ID

NCT00971932

Treatments Being Tested

Cetuximab Cisplatin/Carboplatin 5-Fluorouracil

Previous Next